BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gupta SL, Jaiswal RK. Neutralizing antibody: a savior in the Covid-19 disease. Mol Biol Rep 2022;49:2465-74. [PMID: 34988889 DOI: 10.1007/s11033-021-07020-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Rachman A, Iriani A, Irawan C, Sukrisman L, Rajabto W, Mulansari NA, Lubis AM, Prasetyawaty F, Cahyanur R, Priantono D, Rumondor BB, Betsy R, Juanputra S. Complete blood count derived inflammatory biomarkers and the level of anti-SARS-CoV-2 NAb and S-RBD IgG among cancer survivors receiving COVID-19 vaccines. ELECTRON J GEN MED 2023;20:em456. [DOI: 10.29333/ejgm/12851] [Reference Citation Analysis]
2 Gupta SL, Jaiswal RK. An Assessment of the Bivalent Vaccine as a Second Booster for COVID-19. Vaccines (Basel) 2022;11. [PMID: 36679924 DOI: 10.3390/vaccines11010079] [Reference Citation Analysis]
3 Al-Sheboul SA, Brown B, Shboul Y, Fricke I, Imarogbe C, Alzoubi KH. An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines. Vaccines (Basel) 2022;11. [PMID: 36679897 DOI: 10.3390/vaccines11010051] [Reference Citation Analysis]
4 Noor R. Host Protective Immunity against Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) and the COVID-19 Vaccine-Induced Immunity against SARS-CoV-2 and Its Variants. Viruses 2022;14. [PMID: 36423150 DOI: 10.3390/v14112541] [Reference Citation Analysis]
5 Gupta SL, Basu S, Soni V, Jaiswal RK. Immunotherapy: an alternative promising therapeutic approach against cancers. Mol Biol Rep 2022. [PMID: 35759082 DOI: 10.1007/s11033-022-07525-8] [Reference Citation Analysis]